Editorials
Can EGFR mutation status evolve with chemotherapy?
Chinese Clinical Oncology
2013;
2
(1)
:1
.
(10 January 2013)
EGFR mutation in lung cancer: tumor heterogeneity and the impact of chemotherapy
Chinese Clinical Oncology
2013;
2
(1)
:2
.
(10 January 2013)
Drifting EGFR mutation
Chinese Clinical Oncology
2013;
2
(1)
:3
.
(10 January 2013)
Original Article
Prostate carcinoma in transgenic Lewis rats - a tumor model for evaluation of immunological treatments
Chinese Clinical Oncology
2013;
2
(1)
:4
.
(10 January 2013)
Review Articles
Molecular therapy for gastric cancer
Chinese Clinical Oncology
2013;
2
(1)
:5
.
(10 January 2013)
Current status and future direction of chemotherapy for pancreatic cancer
Chinese Clinical Oncology
2013;
2
(1)
:6
.
(10 January 2013)
The B7-H1/PD-1 pathway in cancers associated with infections and inflammation: opportunities for therapeutic intervention
Chinese Clinical Oncology
2013;
2
(1)
:7
.
(10 January 2013)
Colorectal cancer screening: are stool and blood based tests good enough?
Chinese Clinical Oncology
2013;
2
(1)
:8
.
(10 January 2013)
The future of clinical research in oncology: where are we heading to?
Chinese Clinical Oncology
2013;
2
(1)
:9
.
(10 January 2013)
Perspective
Paradigm of polyendocrine therapy in endocrine responsive breast cancer: the role of fulvestrant
Chinese Clinical Oncology
2013;
2
(1)
:10
.
(10 January 2013)
